Digestive Enzymes

Enzymes break down food; probiotics support gut flora

Comprehensive digestive support

⟡ Betaine HCl

HCl supports stomach acid; enzymes support breakdown

Full digestive support for low-acid conditions

⟡ Ox Bile

Bile emulsifies, lipase digests fats

Complete fat digestion support

Top studies from 40+ peer-reviewed papers

📚meta-analysisn=1781

Noble CCA et al. • The American journal of clinical nutrition (2021)

“Several biological and psychosocial interventions show promise in improving outcomes in children following hospitalization for SAM and require further exploration in larger randomized mortality trials.”

Key Findings:

Compared with standard care, pancreatic enzyme supplementation reduced inpatient mortality (37.8% compared with 18.6%, P < 0.05).
In meta-analysis there was some evidence that prebiotics or synbiotics reduced mortality (RR: 0.72; 95% CI: 0.51, 1.00; P = 0.049).
Psychosocial stimulation reduced mortality in meta-analysis of the 2 trials reporting deaths (RR: 0.36; 95% CI: 0.15, 0.87), and improved neurodevelopmental scores in ≥1 domain in all studies.

📚meta-analysisn=12313

Hirota M et al. • Digestive endoscopy : official journal of the Japan Gastroenterological Endoscopy Society (2024)

“Despite a high risk of bias due to various reference standards, this updated meta-analysis and the utility assessment by a decision tree showed the utility of serum amylase or lipase levels more than 3 times ULN measured 2-4 h after ERCP for predicting PEP.”

Key Findings:

Meta-analysis of eight studies (4389 participants) showed a pooled sensitivity of 71.1% (95% confidence interval [CI] 56.1-82.5) and pooled specificity of 91.2% (95% CI 85.9-94.6) for the serum amylase cut-off value at 3 times the upper limit of normal (ULN).
Another meta-analysis of five studies (1970 participants) showed a pooled sensitivity of 85.8% (95% CI 61.9-95.7) and pooled specificity of 85.3% (95% CI 81.9-88.1) for the serum lipase cut-off value at 3 times ULN.
Despite a high risk of bias due to various reference standards, this updated meta-analysis and the utility assessment by a decision tree showed the utility of serum amylase or lipase levels more than 3 times ULN measured 2-4 h after ERCP for predicting PEP.

📚meta-analysisn=24353

Zhou Y et al. • Frontiers in public health (2022)

“PE elevation was a common phenomenon in patients with COVID-19, and was associated with poor clinical outcomes.”

Key Findings:

In addition, the subgroup analysis revealed that although PE elevated to > 3 × upper normal limit (ULN) was significantly related to the mortality (OR = 4.4, 2.1-9.4), it seemed that mild elevation of PE to 1-3 ULN also had a considerable risk of mortality (OR = 2.3, 1.5-3.5).
PE elevation was a common phenomenon in patients with COVID-19, and was associated with poor clinical outcomes.
However, due to the limited numbers of included studies, the result of our study still needed to be validated.

📚meta-analysisn=1385

Kawamoto M et al. • International journal of cancer (2022)

“Rare variants in CPB1 and CPA1 that induce ER stress are associated with increased odds of developing pancreatic cancer.”

Key Findings:

Of the 1385 patients with PDAC, 0.65% were found to harbor an ER stress-inducing variant in CPA1 or CPB1, compared to 0.17% of the 64 026 controls (odds ratio [OR]: 3.80 [1.92-7.51], P = .0001).
ER stress-inducing variants in the CPA1 gene were identified in 4 of 1385 PDAC cases vs 77 of 64 026 gnomAD controls (OR: 2.4 [0.88-6.58], P = .087), and variants in CPB1 were detected in 5 of 1385 cases vs 33 of 64 026 controls (OR: 7.02 [2.74-18.01], P = .0001).
Meta-analysis demonstrated strong associations for pancreatic cancer and ER-stress inducing variants for both CPA1 (OR: 3.65 [1.58-8.39], P < .023) and CPB1 (OR: 9.51 [3.46-26.15], P < .001).

📚meta-analysisn=6715

Compare with Others Find Based on Your Goals

Ul Ain Q et al. • World journal of gastroenterology (2021)

“Although patients with CP had similar calorie intake to controls, studies that analysed the contribution of alcohol to energy intake showed that patients with CP consumed fewer non-alcohol calories than healthy controls.”

Key Findings:

Those with alcohol-related CP consumed more mean (standard deviation) calories than CP patients with a non-alcohol aetiology [2642 (1090) kcal and 1372 (394) kcal, respectively, P = 0.046], as well as more protein, fat, but not carbohydrate.
Although patients with CP had similar calorie intake to controls, studies that analysed the contribution of alcohol to energy intake showed that patients with CP consumed fewer non-alcohol calories than healthy controls.
A high calorie intake, made up to a large degree by alcohol, may in part contribute to poor nutritional status in CP.

View all 40+ studies

What would you like to do next?

Related Supplements

Brm7.0

Bromelain

Proteolytic enzyme from pineapple that aids digestion with food or provides systemic anti-inflammatory and recovery benefits on an empty stomach.

Ob6.0

Ox Bile

6/10

Supplemental bile acids that restore fat digestion and fat-soluble vitamin absorption after gallbladder removal or bile insufficiency.

Srp7.0

Serrapeptase

Silkworm-derived enzyme that breaks down inflammatory proteins and thins mucus — used in Europe and Japan as an NSAID alternative.

Ge9.0

Ginger Extract

9/10

Gingerols and shogaols reduce nausea, accelerate gastric emptying, and provide systemic anti-inflammatory benefits.

Dge8.5

Digestive Enzymes

enzyme

Digestive Enzyme Complex

Enzyme blend that supports digestion of proteins, fats, carbohydrates, and fiber, reducing bloating and improving nutrient absorption.

bodydigestionbloatinggut healthnutrient absorption

40+ studies

Evidence

Reviewed 19 days ago

high

Safety

1-2 capsules with meals (varies by product)

Dose

0-0 days

Time to Effect

Broad-spectrum enzyme blend capsules

Best Form

Mechanisms of Action

🥩

Protein Digestion

Proteases break down proteins into amino acids

🥑

Fat Digestion

Lipase breaks down fats for absorption

🍞

Carbohydrate Digestion

Amylase and specialty enzymes break down carbs

Biological PathwayBeta

How Digestive Enzymes works — from molecular targets to health outcomes. Click an edge to see supporting research.This visualization is in beta — pathways are being refined and expanded.

Supplement

Molecular Target

Biological Process

Health Outcome

Strong

Moderate

Emerging

strong

moderate

emerging

Tap node to isolate • Pinch to zoom • Tap edge for research

Recommended Dose

1-2 capsules with meals (varies by product)

1capsules4capsules

Loading: Not required

Optimal Timing

At beginning of meals or just before eating

Take with food

Available Forms

Form	Type
💊Broad-spectrum enzyme blend capsules	Recommended
💊Specific enzymes (lactase, alpha-galactosidase)	Alternative
💊Chewables	Alternative

Choose based on specific needs: full-spectrum for general use, lactase for dairy, alpha-galactosidase (Beano) for beans/legumes.

Duration

Minimum: 0 days

Optimal: 0 days

Cycling: Not required

Note: MUST be taken with meals to work. Taking on empty stomach provides no digestive benefit.

💨

Reduced Bloating

Less gas and bloating after meals

⚡ Immediate

70% of users notice thispositive

✨

Better Digestion

Improved comfort after eating

⚡ Immediate

65% of users notice thispositive

🥛

Food Tolerance

Better tolerance of trigger foods

⚡ Immediate

60% of users notice thispositive

High SafetyMax safe dose: Follow product directions

🟢

Pregnant/nursing

Generally safe; consult doctor

🟡

Pancreatic insufficiency

Prescription enzymes may be more appropriate

Who Should NOT Take This

Active ulcers or gastritis (some enzymes may irritate)
Allergy to source (pineapple for bromelain, papaya for papain)

Drug Interactions

Blood thinnersmild

Bromelain/papain may have mild antiplatelet effects — may affect platelet aggregation or vitamin K-dependent clotting factors, altering anticoagulant efficacy

Diabetes medicationsmild

May affect carbohydrate absorption timing

Possible Side Effects

Loose stools

milduncommon

Tip: Reduce dose

Nausea

milduncommon

Tip: Take with food (not on empty stomach)

Mouth irritation (chewables)

mildrare

Tip: Switch to capsules

Warnings

Not a cure for chronic digestive diseases
If symptoms persist, see a doctor
Must be taken with meals to work

⟡ Probiotics

Enzymes break down food; probiotics support gut flora

Comprehensive digestive support

⟡ Betaine HCl

HCl supports stomach acid; enzymes support breakdown

Full digestive support for low-acid conditions

⟡ Ox Bile

Bile emulsifies, lipase digests fats

Complete fat digestion support

Top studies from 40+ peer-reviewed papers

📚meta-analysisn=1781

Noble CCA et al. • The American journal of clinical nutrition (2021)

“Several biological and psychosocial interventions show promise in improving outcomes in children following hospitalization for SAM and require further exploration in larger randomized mortality trials.”

Key Findings:

Compared with standard care, pancreatic enzyme supplementation reduced inpatient mortality (37.8% compared with 18.6%, P < 0.05).
In meta-analysis there was some evidence that prebiotics or synbiotics reduced mortality (RR: 0.72; 95% CI: 0.51, 1.00; P = 0.049).
Psychosocial stimulation reduced mortality in meta-analysis of the 2 trials reporting deaths (RR: 0.36; 95% CI: 0.15, 0.87), and improved neurodevelopmental scores in ≥1 domain in all studies.

📚meta-analysisn=12313

Hirota M et al. • Digestive endoscopy : official journal of the Japan Gastroenterological Endoscopy Society (2024)

“Despite a high risk of bias due to various reference standards, this updated meta-analysis and the utility assessment by a decision tree showed the utility of serum amylase or lipase levels more than 3 times ULN measured 2-4 h after ERCP for predicting PEP.”

Key Findings:

Meta-analysis of eight studies (4389 participants) showed a pooled sensitivity of 71.1% (95% confidence interval [CI] 56.1-82.5) and pooled specificity of 91.2% (95% CI 85.9-94.6) for the serum amylase cut-off value at 3 times the upper limit of normal (ULN).
Another meta-analysis of five studies (1970 participants) showed a pooled sensitivity of 85.8% (95% CI 61.9-95.7) and pooled specificity of 85.3% (95% CI 81.9-88.1) for the serum lipase cut-off value at 3 times ULN.
Despite a high risk of bias due to various reference standards, this updated meta-analysis and the utility assessment by a decision tree showed the utility of serum amylase or lipase levels more than 3 times ULN measured 2-4 h after ERCP for predicting PEP.

📚meta-analysisn=24353

Zhou Y et al. • Frontiers in public health (2022)

“PE elevation was a common phenomenon in patients with COVID-19, and was associated with poor clinical outcomes.”

Key Findings:

In addition, the subgroup analysis revealed that although PE elevated to > 3 × upper normal limit (ULN) was significantly related to the mortality (OR = 4.4, 2.1-9.4), it seemed that mild elevation of PE to 1-3 ULN also had a considerable risk of mortality (OR = 2.3, 1.5-3.5).
PE elevation was a common phenomenon in patients with COVID-19, and was associated with poor clinical outcomes.
However, due to the limited numbers of included studies, the result of our study still needed to be validated.

📚meta-analysisn=1385

Kawamoto M et al. • International journal of cancer (2022)

“Rare variants in CPB1 and CPA1 that induce ER stress are associated with increased odds of developing pancreatic cancer.”

Key Findings:

Of the 1385 patients with PDAC, 0.65% were found to harbor an ER stress-inducing variant in CPA1 or CPB1, compared to 0.17% of the 64 026 controls (odds ratio [OR]: 3.80 [1.92-7.51], P = .0001).
ER stress-inducing variants in the CPA1 gene were identified in 4 of 1385 PDAC cases vs 77 of 64 026 gnomAD controls (OR: 2.4 [0.88-6.58], P = .087), and variants in CPB1 were detected in 5 of 1385 cases vs 33 of 64 026 controls (OR: 7.02 [2.74-18.01], P = .0001).
Meta-analysis demonstrated strong associations for pancreatic cancer and ER-stress inducing variants for both CPA1 (OR: 3.65 [1.58-8.39], P < .023) and CPB1 (OR: 9.51 [3.46-26.15], P < .001).

📚meta-analysisn=6715

Compare with Others Find Based on Your Goals

Ul Ain Q et al. • World journal of gastroenterology (2021)

“Although patients with CP had similar calorie intake to controls, studies that analysed the contribution of alcohol to energy intake showed that patients with CP consumed fewer non-alcohol calories than healthy controls.”

Key Findings:

Those with alcohol-related CP consumed more mean (standard deviation) calories than CP patients with a non-alcohol aetiology [2642 (1090) kcal and 1372 (394) kcal, respectively, P = 0.046], as well as more protein, fat, but not carbohydrate.
Although patients with CP had similar calorie intake to controls, studies that analysed the contribution of alcohol to energy intake showed that patients with CP consumed fewer non-alcohol calories than healthy controls.
A high calorie intake, made up to a large degree by alcohol, may in part contribute to poor nutritional status in CP.

View all 40+ studies

What would you like to do next?

Related Supplements

Brm7.0

Bromelain

Proteolytic enzyme from pineapple that aids digestion with food or provides systemic anti-inflammatory and recovery benefits on an empty stomach.

Ob6.0

Ox Bile

6/10

Supplemental bile acids that restore fat digestion and fat-soluble vitamin absorption after gallbladder removal or bile insufficiency.

Srp7.0

Serrapeptase